Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.68B |
| Enterprise Value | 11.71B |
| P/E Ratio | 106.72 |
| PEG Ratio | 0.29 |
| Price/Sales Ratio | 13.54 |
| Price/Book Ratio | 8.47 |
| Enterprise/Revenue | 12.83 |
| Enterprise/EBITDA | 42.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 1.38B |
| Revenue/Share | 3.45 |
| Gross Profit | 1.05B |
| EBITDA | 419.49M |
| Net Income | 173.2M |
| Diluted EPS | 0.43 |
Balance Sheet
| Total Cash | 1.56B |
| Total Cash/Share | 3.91 |
| Total Debt | 584.09M |
| Total Debt/Equity | 0.27 |
| Current Ratio | 2.31 |
| Book Value Per Share | 5.45 |
Price History
| 52-Week Change | 162.56 |
| 52-Week High | 70.15 |
| 52-Week Low | 19.96 |
| Moving Average 50 Days | 46.68 |
| Moving Average 200 Days | 42.35 |
Statistics
| Average Volume | 1.41M |
| Shares Outstanding | 405.53M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
